Variant report
Variant | esv3440603 |
---|---|
Chromosome Location | chr5:99509102-99539474 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546271336 | chr5:99509802-99509803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11952192 | chr5:99509812-99509813 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs11952934 | chr5:99509815-99509816 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs548584466 | chr5:99509838-99509839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs386690474 | chr5:99509854-99509855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11952199 | chr5:99509858-99509859 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs529503281 | chr5:99509889-99509890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377248356 | chr5:99509899-99509900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145304045 | chr5:99509917-99509918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532924884 | chr5:99509929-99509930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570001630 | chr5:99509978-99509979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6595045 | chr5:99509998-99509999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11949528 | chr5:99510016-99510017 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs369048004 | chr5:99510096-99510097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs62387063 | chr5:99510137-99510138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554232892 | chr5:99510139-99510140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113342587 | chr5:99510140-99510141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11358221 | chr5:99510153-99510154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554219045 | chr5:99510213-99510214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73774588 | chr5:99510238-99510239 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs536895723 | chr5:99510251-99510252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181784428 | chr5:99510253-99510254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537549821 | chr5:99510259-99510260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552794999 | chr5:99510262-99510263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79508143 | chr5:99510290-99510291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368754733 | chr5:99510334-99510335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140682172 | chr5:99510336-99510337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72771028 | chr5:99510366-99510367 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs57716259 | chr5:99510375-99510376 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs558251724 | chr5:99510433-99510434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112980406 | chr5:99510442-99510443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7712846 | chr5:99510443-99510444 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs150096905 | chr5:99510490-99510491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553583680 | chr5:99510496-99510497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76171382 | chr5:99510521-99510522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201195821 | chr5:99510524-99510525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544001440 | chr5:99510603-99510604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7713150 | chr5:99510605-99510606 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs117848647 | chr5:99510607-99510608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541315048 | chr5:99510653-99510654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs57191091 | chr5:99510662-99510663 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs111979239 | chr5:99510670-99510671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186341491 | chr5:99510677-99510678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145507518 | chr5:99510700-99510701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs59771332 | chr5:99510736-99510737 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs191679476 | chr5:99510756-99510757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528466420 | chr5:99510776-99510777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs60398983 | chr5:99510794-99510795 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs567461306 | chr5:99510819-99510820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140313533 | chr5:99510820-99510821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:99509800-99510200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:99510200-99510600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr5:99510600-99512200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr5:99510800-99511800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr5:99510800-99512000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr5:99512200-99517400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr5:99517600-99517800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr5:99521400-99523000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr5:99521600-99522800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr5:99521600-99523200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr5:99521800-99522400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr5:99521800-99522800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr5:99521800-99523000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr5:99521800-99523200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr5:99522000-99522400 | Enhancers | HUES48 Cell Line | embryonic stem cell |